Gene News and Research

Latest Gene News and Research

Salk professor receives $1.2 million from Larry L. Hillblom Foundation for diabetes research

Salk professor receives $1.2 million from Larry L. Hillblom Foundation for diabetes research

Comparison of neutralization of SARS-CoV-2 variants of concern Omicron and Delta

Comparison of neutralization of SARS-CoV-2 variants of concern Omicron and Delta

SARS-CoV-2 appears to persist in organs throughout the body for months

SARS-CoV-2 appears to persist in organs throughout the body for months

Cryo-ET reveals molecular mechanisms underlying gene mutations within the eye

Cryo-ET reveals molecular mechanisms underlying gene mutations within the eye

Scientists discover a division of labor between genetic switches

Scientists discover a division of labor between genetic switches

Analyzing cell-free RNA could reliably predict preeclampsia

Analyzing cell-free RNA could reliably predict preeclampsia

Horizontal gene transfer between viruses and hosts plays a major role in driving evolution

Horizontal gene transfer between viruses and hosts plays a major role in driving evolution

New compound could combat multidrug-resistant pathogens in healthcare settings

New compound could combat multidrug-resistant pathogens in healthcare settings

Folic acid-like drug reprograms DNA methylome of aggressive brain tumors

Folic acid-like drug reprograms DNA methylome of aggressive brain tumors

New CRISPR-based assay can non-invasively detect a biomarker of acute kidney rejection in urine

New CRISPR-based assay can non-invasively detect a biomarker of acute kidney rejection in urine

Wistar announces initiation of Phase 2 clinical study of VK-2019 in patients with advanced head and neck cancer

Wistar announces initiation of Phase 2 clinical study of VK-2019 in patients with advanced head and neck cancer

Hospitalization and death associated with SARS-CoV-2 Omicron variant compared to Delta variant

Hospitalization and death associated with SARS-CoV-2 Omicron variant compared to Delta variant

Nucleocapsid protein preferentially binds to structured and longer RNA to deliver viral proteins in host circulation

Nucleocapsid protein preferentially binds to structured and longer RNA to deliver viral proteins in host circulation

mRNA booster vaccine confers strong protection against SARS-CoV-2 Omicron in cancer patients

mRNA booster vaccine confers strong protection against SARS-CoV-2 Omicron in cancer patients

New gene therapy addresses primary cellular deficit associated with limb-girdle muscular dystrophy 2B

New gene therapy addresses primary cellular deficit associated with limb-girdle muscular dystrophy 2B

Unique nanoparticle can deliver genome editing technology to endothelial cells

Unique nanoparticle can deliver genome editing technology to endothelial cells

Novel insight into the immune characteristics of bats

Novel insight into the immune characteristics of bats

Research provides compelling insights into the complex nature of genomic imprinting in mice

Research provides compelling insights into the complex nature of genomic imprinting in mice

New insights into how tiny bacteria from the environment have adapted to live inside humans

New insights into how tiny bacteria from the environment have adapted to live inside humans

Very high rates of asymptomatic infection with Omicron compared to prior SARS-CoV-2 variants

Very high rates of asymptomatic infection with Omicron compared to prior SARS-CoV-2 variants

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.